FDA delays decision on Moderna vaccine for adolescents
The U.S. Food and Drug Administration requires more time to decide on whether to approve use of Moderna's two-dose COVID-19 vaccine on adolescents 12 to 17 years of age, the pharmaceutical company said. from Latest News - UPI.com https://ift.tt/3pUC8l9 via IFTTT